Notice bibliographique
- Notice
Type(s) de contenu et mode(s) de consultation : Texte noté : sans médiation
Titre(s) : Thyroid cancer [Texte imprimé] : from emergent biotechnologies to clinical practice guidelines / edited by Angelo Carpi, Jeffrey I. Mechanick
Publication : Boca Raton : CRC press, cop. 2011
Description matérielle : 1 vol. (XVII-390 p.-[8] p. de pl.) : ill. ; 27 cm
Note(s) : Notes bibliogr.
"Thyroid cancer evaluation and treatment has enjoyed very little evolution in comparison
with other disease management strategies. The standard treatment algorithms for thyroid
cancer have varied only in response to major, though infrequent, biotechnological
innovations. These resultant algorithm node insertions produced paradigm changes,
but there has been little to advance the care of the patient with advanced thyroid
cancer--until very recently. Perhaps the reasons for a relative lack of interest and
scientific progress are the overwhelming likelihood of benignity among thyroid nodules,
the overwhelmingly favorable clinical outcome even if a patient has thyroid cancer,
and the overwhelming long time required for clinical follow-up of these cancer patients.
Unfortunately, the problem now is that we may be overmanaging low-risk patients, and
we have not achieved the clinical responses we would have liked with high-risk patients"--Provided
by publisher.
Autre(s) auteur(s) : Carpi, Angelo. Éditeur scientifique
Mechanick, Jeffrey I.. Éditeur scientifique
Sujet(s) : Glande thyroïde -- Cancer
Indice(s) Dewey :
616.994 44 (23e éd.) = Cancer de la thyroïde et des parathyroïdes (médecine)
Identifiants, prix et caractéristiques : ISBN 9781439862216 (rel.)
Identifiant de la notice : ark:/12148/cb42507130h
Notice n° :
FRBNF42507130
(notice reprise d'un réservoir extérieur)
